0
Deep & Emerging Tech·July 12, 2026·1 min read

Scientists’ Side Hustle? Using AI and Quantum Computing to Generate New Peptides

Share

AI plus early-stage quantum used to design new peptides for rare diseases is a preview of drug discovery moving from lab-first to compute-first. Biotech operators should map where hybrid classical/quantum workflows could compress target ID and lead optimization long before wet-lab capacity becomes the bottleneck.

Deep & Emerging Tech

The DIY energy boom is here — 30 US states are planning to legalize plug-in solar tech, as home battery installations quietly hit a record high

Plug-in solar and record home battery installs point to a bottom-up grid transition—households are turning into micro-utilities without waiting for rooftop installs or utility programs. Energy and hardware operators should assume a more fragmented, prosumer-heavy landscape and design products that interoperate with ad hoc home setups, not just utility-scale deployments.